JPRN-jRCTs041180179招募中未知
The effect of PHOSPHate control On Renal function in chronic kidney disease patients not on dialysis-PHOSPHOR study - The effect of PHOSPHate control On Renal function in chronic kidney disease patients not on dialysis-PHOSPHOR study
Shigeru Shibata0 个研究点目标入组 160 人开始时间: 2019年3月29日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 160
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20-year-old 至 o setting(—)
- 性别
- All
入选标准
- •1)Patients in adults (over 20 years old)
- •2)No gender
- •3)Patients with eGFR (mL / min / 1.73 m 2) calculated from the serum creatinine value of 15 or more and less than 45 and serum phosphorus value of 4.0 mg / dL or more (including patients taking phosphorus adsorbent)
- •4)Patients whose eGFR (mL / min / 1.73 m 2) calculated from the serum creatinine value is 15 or more and less than 45 and serum phosphorus value is 4.0 mg / dL or more (patients who are taking phosphorus adsorption drugs have no acute renal function change, CKDPatients whose systemic condition is stable as treatment intervention other than administration of phosphorus adsorption is performed according to clinical guide (edited by Japan Society of Nephrology)
- •5)Patients receiving one or more appropriate nutritional guidance
- •6)Patients who agreed to participate in the study
排除标准
- •1)Patients contraindicated for administration of ferric citrate hydrate
- •2)Patients with a history of hypersensitivity to the ingredients of this drug
- •3)Patients with iron overload such as hemochromatosis
- •4)Defective diabetes (HbA1c> 9.0%)
- •5)Uncontrolled hypertension (systolic blood pressure of 170 mmHg or more or diastolic blood pressure of 110 mmHg or more)
- •6)Acute renal failure, nephrotic syndrome, people who have undergone hemodialysis after kidney transplantation
- •7)tumor (no recurrence, do not exclude those who are untreated for 5 years)
- •8)Those who are pregnant, lactating, planning pregnancy during the study
- •9)Persons who are undergoing or are undergoing hormone therapy (HRT) with estrogen
- •10)Patient using Cinacalcet (Regala R)
- •11)Patients who are judged inappropriate by the attending physician (dementia, mental retardation, etc.)
研究者
相似试验
招募中
不适用
The effect of PHOSPHate control On Renal function in chronic kidney disease patients not on dialysishyperphosphatemia chronic kidney disease (CKD)JPRN-UMIN000025161Department of Internal medicine, Teikyo University School of Medicine160
招募中
不适用
Examination of the effects on renal function and prognosis of various diuretics for liver cirrhosisiver cirrhosisJPRN-UMIN000040179Hokkaido University400
已完成
不适用
The effect on the renal functions and blood pressure of DPP-4 Inhibitor for the type 2 diabetic patients .Type 2 diabetesJPRN-UMIN000005337Kanazawa Medical University Diadetes & Endocrinology100
进行中(未招募)
1 期
The effects of increased renal function on the blood concentration dynamics of antibiotic piperacillin/tazobactamThe state of renal hyperfiltration during infection in children and young adults with malignant or non-malignant haematological or oncological diagnosisEUCTR2016-003374-40-EEniversity of Tartu56
尚未招募
不适用
Study of renal function renal protective effect of cooling method in laparoscopic partial nephrectomyRenal cell cacinomaJPRN-UMIN000013867Kansai Medical University30
